In addition to the actions of GLP-1 discussed above, the long acting analogs have also in long-term cardiovascular outcome studies been demonstrated to result in reduced cardiovascular risk, so far only in patients with both T2DM and cardiovascular risk (95, 118, 119), but emerging evidence suggests that this may also apply to individuals without established heart disease
This approval expands treatment options for patients living with diabetes in India
10.1186/s12868-016-0272-9 BMC Neurosci
Conclusion To conclude, a balanced GLP-1 diet plan involves various components and requirements
"In theory, it's safe since it's an FDA-approved medication at a lower dose," said Tan
When stored at -20C, please use it within 1 month